WebIf you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday. Diana Kearney Oxfam America Legal and Shareholder Advocacy Advisor No Address Available Contact Oxfam America Email Learn more about SSRN Profiles WebMar 15, 2024 · March 15, 2024 Diana Kearney. Oxfam and co-filers have filed shareholder proposals at Moderna and Pfizer asking the companies to study how they might transfer Covid-19 vaccine technology and know-how to manufacturers in low- and middle-income countries. The companies’ refusal to transfer mRNA technology is prolonging the Covid …
Transforming Adversary to Ally: Mobilizing Corporate Power for …
WebDiana Kearney Oxfam America COVID-19 Vaccine Technology Transfer. Business Case: Backlash from refusal to share information needed to manufacture vaccines in low-and … WebDiana Kearney Oxfam America COVID-19 Vaccine Technology Transfer Business Case: Backlash from refusal to share information needed to manufacture vaccines in low- and middle-income countries could tarnish pharmaceutical companies’ reputations, threaten their social license to operate, and undermine relations with the U.S. government. Companies: black and green nato watch strap
IN THE Supreme Court of the United States
WebDec 4, 2024 · Diana Kearney Senior Legal and Shareholder Advocacy Advisor at Oxfam America Washington, District of Columbia, United … WebJul 15, 2024 · Co-written with Diana Kearney, an advocacy advisor at Oxfam America, and Paloma Muñoz, director of the Investor Alliance for Human Rights. We almost didn’t get … WebMar 4, 2024 · Diana Kearney, senior legal adviser at Oxfam America, said that "thousands of families at the border can breathe a momentary sigh of relief today" and described the … dave girish and co